Some researches have demonstrated that HHLA2 promotes T-lymphocyte proliferation and cytokine release when interacting with the TMIGD2 receptor, which suggests that HHLA2 and TMIGD2 function through a co-stimulatory pathway to stimulate T cells to eliminate cancer cells [10, 12]. This evidence concerns the gene TMIGD2 and cancer.